Wanbury Ltd hits 20% upper circuit on new Tanuku API plant launch

Wanbury Ltd hit an upper circuit of 20% to ₹195.70 after unveiling its state-of-the-art Tanuku API facility in Andhra Pradesh. The company will produce four high-value APIs, Anti-Tussive, Anti-Diabetic, Anti-Coagulant, targeting ₹100 crore revenue in FY27. The facility aims to tap a ₹5,000 crore global market, strengthening Wanbury’s domestic and international API presence.